Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Companhia Brasileira de Distribuição CBD NYSE

NYSE • Consumer Cyclical • Department Stores • BR • USD

SharesGrow Score
22/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Companhia Brasileira de Distribuição (CBD) is a Department Stores company in the Consumer Cyclical sector, currently trading at $0.45. It has a SharesGrow Score of 21/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $18.8B, +5%/yr average growth. Net income is $2.4B (loss), growing at -11442.2%/yr. Net profit margin is -12.8% (negative). Gross margin is 27.5% (+0.8 pp trend).

Balance sheet: total debt is $8.5B against $2.9B equity (Debt-to-Equity (D/E) ratio 2.91, leveraged). Current ratio is 0.96 (tight liquidity). Debt-to-assets is 43.3%. Total assets: $19.7B.

Analyst outlook: 3 / 6 analysts rate CBD as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 40/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 41/100 (Fail), Future 40/100 (Partial), Income 10/100 (Fail).

CBD SharesGrow Score Overview

33/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 41/100
Gross margin is + market cap
FUTURE 40/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CBD

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
40/100
CBD: +5%/yr revenue is, -11442.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
✗
MOAT Fail
41/100
CBD: Gross margin is 27.5% (+0.8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 41/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
40/100
Analyst outlook: 3 / 6 analysts rate CBD as buy (50%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
CBD: Net profit margin is -12.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.445-4.76
Volume74.43K
Avg Volume (30D)236.53K
Market Cap$218.06M
Beta (1Y)1.17
Share Statistics
EPS (TTM)-3.74
Shares Outstanding$643.21M
IPO Date1996-03-08
Employees110,000
CEOMarcelo Ribeiro Pimentel
Financial Highlights & Ratios
Revenue (TTM)$18.79B
Gross Profit$5.17B
EBITDA$373M
Net Income$-2.41B
Operating Income$-436M
Total Cash$2.65B
Total Debt$8.53B
Net Debt$5.9B
Total Assets$19.7B
Price / Earnings (P/E)-0.1
Price / Sales (P/S)0.01
Analyst Forecast
Rating ConsensusBuy
Analysts Covering6
Buy 50% Hold 50% Sell 0%
Company Info
CountryBR
ExchangeNYSE
CurrencyUSD
ISINUS20440T3005

Price Chart

Track all markets on TradingView
CBD
Companhia Brasileira de Distribuição ↗  ·  NYSE
Consumer Cyclical • Department Stores
0.45 52WK RANGE 4.76

People Also View

LRENY
LRENY
Lojas Renner S.A.
$3.11
-11.14%
 WLWHY
WLWHY
Woolworths Holdings Limited
$3.20
+1.59%
 LENTY
LENTY
Lenta International public joint-stock company
$1.77
+0.00%
 PMDKF
PMDKF
PT. Mitra Adiperkasa Tbk
$0.05
+0.00%
 DDT
DDT
Dillards Capital Trust I CAP SECS 7.5%
$26.40
+0.65%
 SRSCQ
SRSCQ
Sears Canada Inc.
$0.00
+0.00%
 AMZN
AMZN
Amazon.com, Inc.
$248.97
+3.79%
 TSLA
TSLA
Tesla, Inc.
$364.16
+3.33%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message